SpyGlass Pharma, Inc. (SGP) Stock

NASDAQ: SGPHealthcare company in the biotechnology industry, based in Irvine, CA.

SpyGlass Pharma stock price chart

SGP interactive chart →

SGP stock quote & key statistics

SpyGlass Pharma earnings per share

Income →
Earnings per share

SpyGlass Pharma revenue & net income

Income →
RevenueNet income

SpyGlass Pharma annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$0-$39.9M-$0.38
FY2024$0-$29.2M—
FY2023$0-$13.3M—

Fiscal year ending December 31. Source: company filings via EODHD.

About SpyGlass Pharma, Inc.

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients.

It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was headquartered in 2019 and is based in Irvine, California.

SpyGlass Pharma stock FAQ

What is the SpyGlass Pharma stock ticker symbol?

SpyGlass Pharma, Inc. trades on the NASDAQ under the ticker symbol SGP.

What sector and industry is SpyGlass Pharma in?

SpyGlass Pharma, Inc. is classified in the Healthcare sector, Biotechnology industry.

How many employees does SpyGlass Pharma have?

SpyGlass Pharma, Inc. has about 76 full-time employees.

What were SpyGlass Pharma's revenue and earnings last fiscal year?

SpyGlass Pharma reported revenue of $0 and net income of -$39.9M in fiscal 2025, with earnings per share of -$0.38.

Is SpyGlass Pharma in the Russell 2000?

Yes. SpyGlass Pharma, Inc. (SGP) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.

When did SpyGlass Pharma go public?

SpyGlass Pharma stock began trading on February 6, 2026.

Russell 2000 Biotechnology stocks

All Russell 2000 →